Skip to main content

Table 2 Associations with mortality in AIDS-KS patients

From: AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa

Mortality

 

Unadjusted

Adjusted

 

HR

95% CI

P

HR

95% CI

P

Gender

      

   Male

1.0

     

   Female

1.0

(0.6-1.7)

0.863

1.3

(0.7-2.2)

0.399

Age

      

   ≤35 years

1.0

     

   >35 years

1.2

(0.7-2.0)

0.430

1.6

(0.9-2.8)

0.107

Baseline CD4 count

      

   ≤100 cells/μl

1.0

     

   >100 cells/μl

0.5

(0.3-0.9)

0.025

0.8

(0.5-1.5)

0.556

KS Stage

      

   T0

1.0

     

   T1

3.5

(1.8-6.8)

<0.001

5.3

(2.7-10.6)

<0.001

   S0

1.0

     

   S1

5.7

(1.8-18-1)

0.003

5.1

(1.5-17.0)

0.008

cART

      

   Yes

1.0

     

   No

1.5

(0.8-2.8)

0.172

1.4

(0.7-2.8)

0.355

Chemotherapy

      

   Yes

1.0

     

   No

1.2

(0.7-2.2)

0.482

2.4

(1.2-4.8)

0.012

Radiation Therapy

      

   Yes

1.0

     

   No

1.3

(0.7-2.3)

0.398

1.1

(0.6-2.1)

0.668

  1. KS, Kaposi's sarcoma. HR, Hazards ratio. cART, combination antiretroviral therapy